DNA Bridges, Inc. Corporate Logo Bridging Science and Products Industry and Client News on Twitter Like Us on Facebook Business Intelligence on LinkedIn
HOMESERVICESABOUT DNA BRIDGES, INC.CLIENTSNEWSROOMCONTACT US

Repositioned company in antibody space leading to series B and a $500 million USD partnership deal

CORE CORPORATE STRATEGY SERVICES

Corporate and technology positioning for funding and/or acquisitions
Structuring and negotiation of partnerships and alliances
Market analysis
Technology evaluation and due diligence
Business plan development/review
Product management and support
Patent research and analysis
Brand and corporate communications
Bioprocess and manufacturing

PROVEN RESULTS

Developed strategies that have raised over $120 million USD in corporate financing
Repositioned company in antibody space leading to series B and a $500 million USD
   partnership deal
Closed over 35 partnership deals for clients
Developed/executed 3 year strategy to take early company to profitability
Marketing strategy that led to $12 Million in private financing
Developed business strategy for an emerging translational medicine institute
Developed IP strategy to allow client a license-free development program in the
   monoclonal antibody space

BIOPROCESSING AND MANUFACTURING SERVICES

Bioprocess troubleshooting and process development guidance
Technology, facilities and equipment evaluation
Due diligence for development programs
Due diligence for process and manufacturing related IP
Contract vendor arrangements and management
Management of process/technology transfer and its implementation
Project management: CMC and Drug Development
CMC regulatory submission preparation and review
Corporate and technology positioning

EXPERTISE

Process development utilizing mammalian, E. coli and yeast hosts
Manufacturing strategies
Expression technologies and cell line development strategies
Downstream process development
Biopharmaceuticals manufacturing, pre IND through commercial
Facilities layout, design and evaluation
Broad range of experience with biologics development, including monoclonal antibodies, growth
   factors, cytokines and the clotting cascade

CORPORATE FACT SHEETS

 

 

 

Sound Research

Strategic Planning

Intelligent Solutions

"DNA Bridges was very good at bringing in other experts. They were instrumental in getting the opinions of important people about this project and doing the necessary preliminary PR."

- Project leader at biotech start-up.

An independent third party conducted a quality survey for DNA Bridges,Inc. The third party, in association with Dunn and Bradstreet, interviewed several clients. All clients stated that the costs met expectations and projects were competed on time.